Rubius Therapeutics's activity chart (see below) currently has 29 price targets and 28 ratings on display.
Analysts' price targets on this stock were met 49.44% of the time, taking 127.5 days on average.
Most recent stock forecast was given by MICHAEL SCHMIDT from GUGGENHEIM on 13-Sep-2022. First documented stock forecast 13-Aug-2018.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold
$5
4 years 2 months 7 days ago
(13-Sep-2022)
2/4 (50%)
$2.59 (107.47%)
488
Hold
$1.5
$2
4 years 2 months 11 days ago
(09-Sep-2022)
0/4 (0%)
$0.38 (33.93%)
Hold
$1
4 years 3 months 11 days ago
(09-Aug-2022)
4/5 (80%)
$0.2 (25.00%)
245
Hold
4 years 6 months 9 days ago
(11-May-2022)
2/3 (66.67%)
$0.49 (5.15%)
5
Buy
4 years 6 months 9 days ago
(11-May-2022)
0/3 (0%)
$9.71 (32.06%)
What is RUBY (Rubius Therapeutics) average time for price targets to be met?
Which analyst most recently updated their price target on RUBY (Rubius Therapeutics)?
Which analyst has the lowest performance score on RUBY (Rubius Therapeutics) with a proven track record?
Which analyst has the most public recommendations on RUBY (Rubius Therapeutics)?
Which analyst is the currently most bullish on RUBY (Rubius Therapeutics)?
Which analyst is the currently most reserved on RUBY (Rubius Therapeutics)?